
    
      Adult participants with a diagnosis of MM who have received at least one previous treatment
      line and have experienced symptomatic relapse and/or refractory disease in the previous 6
      months, who are still in follow-up at the time of the study visit will be observed in this
      study.

      The study will look into sociodemographic data, current clinical and therapeutic data,
      clinical data relative to the latest relapse and clinical data at diagnosis and previous
      relapses will be collected.

      The study will enroll approximately 350 patients.

      This multi-center trial will be conducted in a total of 30 public sites in Spain. The overall
      time to collect data will be approximately 1 year from June 2017 to May 2018.
    
  